[HTML][HTML] Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension

W Xu, SC Erzurum - Comprehensive Physiology, 2011 - ncbi.nlm.nih.gov
Pulmonary arterial hypertension (PAH) is a fatal disease characterized by impaired
regulation of pulmonary hemodynamics and excessive growth and dysfunction of the …

Mitochondrial and metabolic drivers of pulmonary vascular endothelial dysfunction in pulmonary hypertension

Q Yu, SY Chan - Pulmonary vasculature redox signaling in health and …, 2017 - Springer
Pulmonary hypertension (PH) is a deadly and increasingly prevalent vascular disease
characterized by excessive pulmonary vascular remodeling and right ventricular dysfunction …

The metabolic basis of pulmonary arterial hypertension

G Sutendra, ED Michelakis - Cell metabolism, 2014 - cell.com
Pulmonary arterial hypertension (PAH) is a vascular remodeling disease of the lungs
resulting in heart failure and premature death. Although, until recently, it was thought that …

Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension

JA Leopold, BA Maron - International journal of molecular sciences, 2016 - mdpi.com
Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by
hypertrophic pulmonary vascular remodeling of distal arterioles to increase pulmonary artery …

Endothelial cells in the pathogenesis of pulmonary arterial hypertension

CE Evans, ND Cober, Z Dai… - European Respiratory …, 2021 - Eur Respiratory Soc
Pulmonary arterial hypertension (PAH) is a devastating disease that involves pulmonary
vasoconstriction, small vessel obliteration, large vessel thickening and obstruction, and …

[HTML][HTML] Metabolic reprogramming, oxidative stress, and pulmonary hypertension

MD Pokharel, DP Marciano, P Fu, MC Franco… - Redox biology, 2023 - Elsevier
Mitochondria are highly dynamic organelles essential for cell metabolism, growth, and
function. It is becoming increasingly clear that endothelial cell dysfunction significantly …

Pulmonary arterial hypertension: New pathophysiological insights and emerging therapeutic targets

A Bourgeois, J Omura, K Habbout, S Bonnet… - The international journal …, 2018 - Elsevier
Pulmonary arterial hypertension (PAH) encompasses a group of clinical entities
characterized by sustained vasoconstriction and progressive vascular remodeling that act in …

Reactive oxygen and nitrogen species in pulmonary hypertension

DM Tabima, S Frizzell, MT Gladwin - Free Radical Biology and Medicine, 2012 - Elsevier
Pulmonary vascular disease can be defined as either a disease affecting the pulmonary
capillaries and pulmonary arterioles, termed pulmonary arterial hypertension, or a disease …

Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension

FA Masri, W Xu, SAA Comhair… - … of Physiology-Lung …, 2007 - journals.physiology.org
Idiopathic pulmonary arterial hypertension (IPAH) is characterized by plexiform vascular
lesions, which are hypothesized to arise from deregulated growth of pulmonary artery …

The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis—ten years later

CD Cool, WM Kuebler, HJ Bogaard… - … of Physiology-Lung …, 2020 - journals.physiology.org
Severe forms of pulmonary arterial hypertension (PAH) are most frequently the
consequence of a lumen-obliterating angiopathy. One pathobiological model is that the …